TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15223897

Group type: EXPERIMENTAL
Intervention: Cyclosporine
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 21
Study: 11880014

Group type: EXPERIMENTAL
Intervention: Clonidine 300 microg orally at 120 minutes before the induction of anesthesia
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 44
Study: 11314428

Group type: EXPERIMENTAL
Intervention: Immediate complete dentures after dense hydroxyapatite implantation into canine sockets
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional immediate dentures
Number of subjects: 0
Study: 8519719

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.25% infused at a rate of 5 mL/h
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no bupivacaine infusion)
Number of subjects: 0
Study: 2226911

Group type: EXPERIMENTAL
Intervention: Cyclic regimen of 0.625 mg/d of conjugated equine estrogens for 25 days/month and 10 mg medroxyprogesterone acetate for the last 13 days of E
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Continuous regimen of 0.625 mg/d of conjugated equine estrogens along with 5 mg medroxyprogesterone acetate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Continuous regimen of 0.625 mg/d of conjugated equine estrogens along with 10 mg medroxyprogesterone acetate
Number of subjects: 0
Study: 322689

Group type: EXPERIMENTAL
Intervention: Chemotherapy with immunotherapy
Number of subjects: 139

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 139
Study: 30001712

Group type: EXPERIMENTAL
Intervention: FF/VI 100/25 mcg
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 27405596

Group type: EXPERIMENTAL
Intervention: Convalescent plasma therapy for MERS-CoV infection
Number of subjects: 582
Study: 23319466

Group type: EXPERIMENTAL
Intervention: Mean daily counts per minute (CPM)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Mean daily steps per day
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Minutes of moderate or vigorous PA (MVPA) per day
Number of subjects: 32
Study: 22561385

Group type: EXPERIMENTAL
Intervention: Ultrasonography-guided corticosteroid injections
Number of subjects: 46

Group type: COMPARATOR
Intervention: Blind corticosteroid injections
Number of subjects: 46
Study: 19809328

Group type: EXPERIMENTAL
Intervention: DCI laryngoscope
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: GlideScope
Number of subjects: 120

Group type: COMPARATOR
Intervention: Direct laryngoscope
Number of subjects: 120
Study: 18051910

Group type: EXPERIMENTAL
Intervention: SCTXLC 0.26 g (4 capsules, three times a day) for 28 days
Number of subjects: 144

Group type: COMPARATOR
Intervention: CCTXLC 0.38 g (4 capsules, three times a day) for 28 days
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: SCTXLC
Number of subjects: 144

Group type: COMPARATOR
Intervention: CCTXLC
Number of subjects: 144
Study: 15618251

Group type: EXPERIMENTAL
Intervention: Tight fitting undertrousers
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Loose fitting undertrousers
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: No undertrousers
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Walking (3.0 km/h)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sitting
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Right scrotal side
Number of subjects: 50

Group type: COMPARATOR
Intervention: Left scrotal side
Number of subjects: 50
Study: 12042618

Group type: EXPERIMENTAL
Intervention: Intragraft 200 µg verapamil
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo (no verapamil)
Number of subjects: 22
Study: 9539491

Group type: EXPERIMENTAL
Intervention: Stenting of the infarct-related artery within 1 week of AMI
Number of subjects: 32
Study: 7876926

Group type: EXPERIMENTAL
Intervention: Intravenous nutrient mixture
Number of subjects: 9

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Intravenous nutrients
Number of subjects: 9
Study: 2296477

Group type: EXPERIMENTAL
Intervention: Structured encounter form
Number of subjects: 1031

Group type: COMPARATOR
Intervention: Basic clinic form
Number of subjects: 1031

Group type: COMPARATOR
Intervention: Unobserved control group
Number of subjects: 1031
Study: 350512

Group type: EXPERIMENTAL
Intervention: Tolamolol 50 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Propranolol 40 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tolamolol 100 mg
Number of subjects: 0
Study: 30610858

Group type: EXPERIMENTAL
Intervention: Web-based educational tool
Number of subjects: 189
Study: 29423451

Group type: EXPERIMENTAL
Intervention: Out-of-hospital continuing nursing
Number of subjects: 180

Group type: COMPARATOR
Intervention: Routine discharge guidance (Control)
Number of subjects: 180
Study: 25440679

Group type: EXPERIMENTAL
Intervention: Polyglycolic acid (PGA) sheets and fibrin glue
Number of subjects: 41

Group type: COMPARATOR
Intervention: Historical control (no PGA sheets and fibrin glue)
Number of subjects: 41
Study: 22729966

Group type: EXPERIMENTAL
Intervention: High information (live video feed of colposcopy)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Low information (complete audiovisual distraction)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Control
Number of subjects: 111
Study: 22140497

Group type: EXPERIMENTAL
Intervention: verum (local anaesthetic) injection
Number of subjects: 60

Group type: COMPARATOR
Intervention: placebo (sodium chloride) injection
Number of subjects: 60

Group type: COMPARATOR
Intervention: sham injection
Number of subjects: 60
Study: 16860174

Group type: EXPERIMENTAL
Intervention: NA/EE 0.5 mg/2.5 μg
Number of subjects: 1750

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1750
Study: 12905089

Group type: EXPERIMENTAL
Intervention: Resistance training (RT) for 10 weeks
Number of subjects: 18
Study: 10706579

Group type: EXPERIMENTAL
Intervention: Low-fat diet (AAD: 37%, Step-1: 28%, Step-2: 24% total fat) for 6 weeks
Number of subjects: 0
Study: 9094064

Group type: EXPERIMENTAL
Intervention: ALS cases
Number of subjects: 8

Group type: COMPARATOR
Intervention: Neurological controls
Number of subjects: 8
Study: 7512661

Group type: EXPERIMENTAL
Intervention: 1 mg finasteride
Number of subjects: 1645

Group type: EXPERIMENTAL
Intervention: 5 mg finasteride
Number of subjects: 1645

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1645

Group type: EXPERIMENTAL
Intervention: Extension study (5 mg finasteride for all patients)
Number of subjects: 1645
Study: 3063798

Group type: EXPERIMENTAL
Intervention: Captopril 50 mg
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 31053766

Group type: EXPERIMENTAL
Intervention: Docetaxel treatment
Number of subjects: 1050
Study: 30318163

Group type: EXPERIMENTAL
Intervention: Bardoxolone methyl (20 mg once daily)
Number of subjects: 2185

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2185
Study: 24485178

Group type: EXPERIMENTAL
Intervention: Simulation training with the MT model
Number of subjects: 24

Group type: COMPARATOR
Intervention: No simulation training (Control)
Number of subjects: 24
Study: 22734676

Group type: EXPERIMENTAL
Intervention: Cardiac contractility modulation (CCM)
Number of subjects: 641

Group type: COMPARATOR
Intervention: Sham treatment or usual care (Control)
Number of subjects: 641
Study: 20107882

Group type: EXPERIMENTAL
Intervention: Cognitive load
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Compassionate affective response
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Expectancy violation
Number of subjects: 189
Study: 18425402

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 12.5 or 25 mg/day
Number of subjects: 265

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 265
Study: 15750456

Group type: EXPERIMENTAL
Intervention: Engerix-B 10 microg (EB)
Number of subjects: 2255

Group type: COMPARATOR
Intervention: Recombivax-HB 2.5 microg (RB)
Number of subjects: 2255

Group type: COMPARATOR
Intervention: Recombivax-HB 5 microg (RB)
Number of subjects: 2255
Study: 12941197

Group type: EXPERIMENTAL
Intervention: Laparoscopic radical prostatectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Laparoscopic cytoreductive nephrectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Minimally invasive nephron‐sparing approaches (cryoablation, radiofrequency ablation, laparoscopic partial nephrectomy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Laparoscopic radical cystectomy with urinary diversion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Laparoscopic retroperitoneal lymph node dissection
Number of subjects: 0
Study: 10792338

Group type: EXPERIMENTAL
Intervention: Spironolactone (200 mg/day)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Cyproterone acetate (CPA) (50 mg/day) with ethinyl oestradiol (35 microgram/day)
Number of subjects: 46
Study: 8538441

Group type: EXPERIMENTAL
Intervention: Read and do
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Read and see experimenter do
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Read and see
Number of subjects: 0

Group type: COMPARATOR
Intervention: Read only
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Read and imagine
Number of subjects: 0
Study: 2041443

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A
Number of subjects: 13

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 13
Study: 6895140

Group type: EXPERIMENTAL
Intervention: antirheumatic drugs
Number of subjects: 62

Group type: COMPARATOR
Intervention: standardised reference region
Number of subjects: 62
Study: 30247523

Group type: EXPERIMENTAL
Intervention: Educational intervention regarding CBC-DIFF uses
Number of subjects: 12036

Group type: EXPERIMENTAL
Intervention: EMR intervention (reprioritization of CBC-DIFF and CBC in electronic medical record orders)
Number of subjects: 12036
Study: 26658900

Group type: EXPERIMENTAL
Intervention: High phenolic content olive oil (HPC) - 366 mg/kg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Low phenolic content olive oil (LPC) - 2.7 mg/kg
Number of subjects: 18
Study: 26465747

Group type: EXPERIMENTAL
Intervention: EN+ (integrated echocardiography/fluoroscopy guidance)
Number of subjects: 34

Group type: COMPARATOR
Intervention: EN- (no guidance)
Number of subjects: 34
Study: 23751152

Group type: EXPERIMENTAL
Intervention: Sublingual 400 μg misoprostol and 100 mg diclofenac
Number of subjects: 255

Group type: COMPARATOR
Intervention: 100 mg diclofenac alone (control group)
Number of subjects: 255
Study: 22088285

Group type: EXPERIMENTAL
Intervention: Endoscope-assisted resection via RAHI
Number of subjects: 28

Group type: COMPARATOR
Intervention: Conventional transcervical approach resection
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 28
Study: 19643157

Group type: EXPERIMENTAL
Intervention: Whole grain high-fiber barley
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Whole grain wheat
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Refined rice
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control (refined rice-based foods)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control (whole grain wheat)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control (whole grain high-fiber barley)
Number of subjects: 47
Study: 17684984

Group type: EXPERIMENTAL
Intervention: Closed aspiration systems
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard aspiration systems (implied control)
Number of subjects: 0
Study: 15080356

Group type: EXPERIMENTAL
Intervention: Submucosal midazolam (0.2 mg/kg) and oral chloral hydrate (50 mg/kg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Oral chloral hydrate (50 mg/kg) and submucosal saline placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups (SM midazolam and saline placebo)
Number of subjects: 20
Study: 11483904

Group type: EXPERIMENTAL
Intervention: Tolterodine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oxybutynin
Number of subjects: 0
Study: 9559472

Group type: EXPERIMENTAL
Intervention: Silicone IOL
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: AcrySof IOL
Number of subjects: 90

Group type: COMPARATOR
Intervention: PMMA IOL
Number of subjects: 90
Study: 11271254

Group type: EXPERIMENTAL
Intervention: FK 506
Number of subjects: 121

Group type: COMPARATOR
Intervention: CsA
Number of subjects: 121
Study: 2840278

Group type: EXPERIMENTAL
Intervention: High soluble fibre (HSF) meal
Number of subjects: 10

Group type: COMPARATOR
Intervention: Low fibre (LF) meal
Number of subjects: 10

Group type: COMPARATOR
Intervention: High insoluble fibre (HIF) meal
Number of subjects: 10
Study: 31743165

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (250 mg IV, 2 doses)
Number of subjects: 251

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 251
Study: 28460864

Group type: EXPERIMENTAL
Intervention: 0.5% ropivacaine
Number of subjects: 153

Group type: COMPARATOR
Intervention: Normal saline solution
Number of subjects: 153

Group type: COMPARATOR
Intervention: Natural history group (no therapy)
Number of subjects: 153
Study: 25324500

Group type: EXPERIMENTAL
Intervention: Migraine attack (untreated)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Headache-free period
Number of subjects: 39
Study: 23068566

Group type: EXPERIMENTAL
Intervention: Self-enhancing feedback from partner
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Self-verifying feedback from partner
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Devaluing feedback from partner
Number of subjects: 192
Study: 19925567

Group type: EXPERIMENTAL
Intervention: Sertaconazole cream (2%) applied topically twice daily for 2 weeks
Number of subjects: 260

Group type: COMPARATOR
Intervention: Miconazole cream (2%) applied topically twice daily for 2 weeks
Number of subjects: 260
Study: 18697865

Group type: EXPERIMENTAL
Intervention: E2 supplementation (transdermal for 3 weeks)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: E2 supplementation
Number of subjects: 20

Group type: COMPARATOR
Intervention: No E2
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Pilot iv bolus ghrelin infusions
Number of subjects: 20
Study: 16949487

Group type: EXPERIMENTAL
Intervention: Cardiac stress-testing (n = 386)
Number of subjects: 770

Group type: COMPARATOR
Intervention: No testing (n = 384)
Number of subjects: 770

Group type: EXPERIMENTAL
Intervention: Both groups (testing and no testing) with HR <65 beats/min
Number of subjects: 770

Group type: EXPERIMENTAL
Intervention: Both groups (testing and no testing) with HR >=65 beats/min
Number of subjects: 770
Study: 14556812

Group type: EXPERIMENTAL
Intervention: Tamoxifen citrate 20 mg/d and testosterone undecanoate 120 mg/d (n = 106)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Placebo treatment (n = 106)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Active treatment group (n = 106)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Placebo group (n = 106)
Number of subjects: 212
Study: 10972169

Group type: EXPERIMENTAL
Intervention: Jejunal pouch reconstruction
Number of subjects: 34

Group type: COMPARATOR
Intervention: Roux-en-Y reconstruction
Number of subjects: 34
Study: 8958461

Group type: EXPERIMENTAL
Intervention: Allegation informed interview technique (196 interviews)
Number of subjects: 1535

Group type: COMPARATOR
Intervention: Allegation blind interview technique (1,330 interviews)
Number of subjects: 1535
Study: 1526694

Group type: EXPERIMENTAL
Intervention: Prednisone therapy
Number of subjects: 18
Study: 3966649

Group type: EXPERIMENTAL
Intervention: 30 ml of 0.3 molar sodium citrate less than 60 min preoperatively (n = 11)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 30 ml of 0.3 molar sodium citrate longer than 60 min preoperatively (n = 11)
Number of subjects: 32

Group type: COMPARATOR
Intervention: No antacid (control group, n = 10)
Number of subjects: 32
Study: 30346822

Group type: EXPERIMENTAL
Intervention: Vacuderm (single-use tourniquet with manual vacuum pump)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard procedure (without Vacuderm)
Number of subjects: 20
Study: 27183035

Group type: EXPERIMENTAL
Intervention: Tai Chi (2 times per week for 12 weeks)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Physical therapy (2 times per week for 6 weeks, followed by 6 weeks of monitored home exercise)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Tai Chi
Number of subjects: 204

Group type: COMPARATOR
Intervention: Physical therapy
Number of subjects: 204
Study: 25305179

Group type: EXPERIMENTAL
Intervention: Exercise Training (ET)
Number of subjects: 34
Study: 22492374

Group type: EXPERIMENTAL
Intervention: MTHFR C677T TT genotype
Number of subjects: 5925
Study: 20388073

Group type: EXPERIMENTAL
Intervention: Intra-articular hyaluronic acid (HA) injection
Number of subjects: 0
Study: 18063205

Group type: EXPERIMENTAL
Intervention: Granisetron 2 mg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Ondansetron 4 mg
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 16303721

Group type: EXPERIMENTAL
Intervention: Subcapsular orchiectomy
Number of subjects: 86

Group type: COMPARATOR
Intervention: Total orchiectomy
Number of subjects: 86
Study: 11994042

Group type: EXPERIMENTAL
Intervention: Gemcitabine plus best supportive care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gemcitabine/cisplatin
Number of subjects: 0
Study: 9466504

Group type: EXPERIMENTAL
Intervention: Conductivity method
Number of subjects: 31

Group type: COMPARATOR
Intervention: Low-flow technique
Number of subjects: 31
Study: 7610459

Group type: EXPERIMENTAL
Intervention: Cefteram-pivoxil (CFTM-PI)
Number of subjects: 0
Study: 2673130

Group type: EXPERIMENTAL
Intervention: Imipramine hydrochloride
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Phenelzine sulfate
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 5443056

Group type: EXPERIMENTAL
Intervention: Silastic vaginal ring impregnated with medroxyprogesterone acetate
Number of subjects: 3

Group type: COMPARATOR
Intervention: Silastic vaginal ring without medication (Control)
Number of subjects: 3
Study: 30985624

Group type: EXPERIMENTAL
Intervention: Hybrid treatment (n=58, 10-16 sessions)
Number of subjects: 115

Group type: COMPARATOR
Intervention: iCBT (n=57; 8 treatment modules)
Number of subjects: 115
Study: 28668073

Group type: EXPERIMENTAL
Intervention: Sentinel lymph node biopsy
Number of subjects: 1644

Group type: COMPARATOR
Intervention: No sentinel lymph node biopsy
Number of subjects: 1644
Study: 26015389

Group type: EXPERIMENTAL
Intervention: Eggs rich in C18:3 ω‐3, eicosapentaenoic acid (EPA, 20:5 ω‐3) and docosahexaenoic acid (DHA, 22:6 ω‐3) for 3 months
Number of subjects: 179

Group type: COMPARATOR
Intervention: Ordinary eggs (control group)
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Eggs rich in ω‐3 PUFAs
Number of subjects: 179
Study: 23736523

Group type: EXPERIMENTAL
Intervention: Memory-based pursuit
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Popping out of the correct spot to enhance retinal image-motion inputs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Initial blanking of spot motion during memory-based pursuit
Number of subjects: 0
Study: 21355444

Group type: EXPERIMENTAL
Intervention: Test formulation of pioglitazone 45 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reference product of pioglitazone 45 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Truncated AUCs
Number of subjects: 0
Study: 19954060

Group type: EXPERIMENTAL
Intervention: mRNA expression of functional genes of neutrophils, monophagocytes, IFN regulating factors, TNF, adhesion molecules and T cells in PE patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: mRNA expression of B cell immune function and complement activation associated factors in PE patients
Number of subjects: 0
Study: 17000504

Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 54

Group type: COMPARATOR
Intervention: Gemeprost
Number of subjects: 54
Study: 15543397

Group type: EXPERIMENTAL
Intervention: Urethral catheter removal after 7 days (Group 1)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Urethral catheter removal after 14 days (Group 2)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Both groups (7 days and 14 days)
Number of subjects: 73
Study: 10834777

Group type: EXPERIMENTAL
Intervention: Bupivacaine 8 mg + Fentanyl 10 microg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Bupivacaine 10 mg + Fentanyl 10 microg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Bupivacaine 12 mg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Bupivacaine 12 mg + Fentanyl 10 microg
Number of subjects: 120
Study: 9105817

Group type: EXPERIMENTAL
Intervention: Warm cardioplegia
Number of subjects: 1374

Group type: COMPARATOR
Intervention: Cold cardioplegia
Number of subjects: 1374

Group type: EXPERIMENTAL
Intervention: Warm cardioplegia (low risk)
Number of subjects: 1374

Group type: COMPARATOR
Intervention: Cold cardioplegia (low risk)
Number of subjects: 1374

Group type: EXPERIMENTAL
Intervention: Warm cardioplegia (high risk)
Number of subjects: 1374

Group type: COMPARATOR
Intervention: Cold cardioplegia (high risk)
Number of subjects: 1374
Study: 7681510

Group type: EXPERIMENTAL
Intervention: Felodipine after 1 week of oral ramipril
Number of subjects: 12

Group type: COMPARATOR
Intervention: Felodipine after placebo
Number of subjects: 12

Group type: COMPARATOR
Intervention: Solvent after ramipril
Number of subjects: 12
Study: 3092654

Group type: EXPERIMENTAL
Intervention: Enprostil 35 micrograms intragastrically
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Enprostil 70 micrograms intragastrically
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Enprostil 35 micrograms intraduodenally
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Enprostil 70 micrograms intraduodenally
Number of subjects: 6

Group type: COMPARATOR
Intervention: Ranitidine 150 mg intragastrically
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 31721089

Group type: EXPERIMENTAL
Intervention: Cinnamon capsules for 60 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Orlistat twice daily for 30 days, then once daily for another 30 days
Number of subjects: 0
Study: 30194826

Group type: EXPERIMENTAL
Intervention: Immediate intervention group (online course during the first internship)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Delayed intervention group (online course during the second internship)
Number of subjects: 36
Study: 26201085

Group type: EXPERIMENTAL
Intervention: Tocilizumab treatment
Number of subjects: 20
Study: 23389863

Group type: EXPERIMENTAL
Intervention: Exercise group (EG) - exercise class including pelvic floor muscle training (PFMT)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Control group (CG) - usual care
Number of subjects: 169